S.-Y. Cheng et al. / Bioorg. Med. Chem. 17 (2009) 3763–3769
3769
J = 8.0 Hz, H-3), 5.08 (1H, br d, J = 5.2 Hz, H-11), 4.44 (1H, dt, J = 9.2,
3.2 Hz, H-14), 4.14 (1H, d, J = 11.6 Hz, H-18a), 4.07 (1H, d,
J = 11.6 Hz, H-18b), 3.45 (3H, s, OCH3), 2.92 (1H, m, H-1), 2.44 (1H,
br d, J = 11.6 Hz, H-13a), 2.05 (3H, s, 18-OAc), 2.05 (1H, m, H-2a),
2.00 (1H, m, H-5a), 1.72 (1H, m, H-5b), 1.69 (1H, m, H-2b), 1.64
(3H, s, Me-20), 1.62 (3H, s, Me-19). Selected 1H NMR (CDCl3,
400 MHz) of 5a: dH 7.41–7.57 (5H, m, Ph), 6.33 (1H, d, J = 3.2 Hz, H-
17a), 6.03 (1H, d, J = 3.2 Hz, H-17b), 5.63 (1H, br t, J = 6.0 Hz, H-11),
5.38 (1H, br d, J = 8.8 Hz, H-7), 5.28 (1H, d, J = 8.8 Hz, H-13), 4.11
(1H, dd, J = 10.8, 2.8 Hz, H-14), 3.55 (3H, s, OCH3), 2.94 (1H, m, H-
1), 2.82 (1H, m, H-3), 1.74 (3H, s, Me-20), 1.72 (3H, s, Me-19), 1.26
(3H, s, Me-18); Selected 1H NMR(CDCl3, 400 MHz) of 5b: dH 7.40–
7.58 (5H, m, Ph), 6.34 (1H, d, J = 3.2 Hz, H-17a), 6.03 (1H, d,
J = 3.2 Hz, H-17b), 5.52 (1H, br t, J = 6.0 Hz, H-11), 5.37 (1H, br d,
J = 8.8 Hz, H-7), 5.17 (1H, d, J = 8.8 Hz, H-13), 4.16 (1H, dd, J = 10.8,
2.8 Hz, H-14), 3.55 (3H, s, OCH3), 2.95 (1H, m, H-1), 2.83 (1H, m, H-
3), 1.72 (3H, s, Me-20), 1.71 (3H, s, Me-19), 1.26 (3H, s, Me-18).
Plus) according to the manufacturer, Sigma Chemical Company, St.
Louis, MO, mark an inner of CAPE in var. paragraph instructions.
3.8. Inhibition of endonuclease activity assay
The HCMV UL76 encodes an endonuclease32 was purified from
E. coli BL21-codon DE3-RIL strain, which was transformed with cal-
modulin-tagged UL76 plasmid pCBP-UL76. The double-stranded
supercoiled DNA uX174 was purified by CsCl gradient and used
as substrate.33 Tested compounds were series diluted and incu-
bated with 1 lg DNA substrate, reaction buffer and UL76 endonu-
clease at 37 °C for 1 h. After cleavage reaction, DNA was resolved in
1% agarose gel. Concentrations of tested compounds that exert 50%
of inhibition of cleaved substrate (IC50) were recorded.
Acknowledgments
This work was supported by grants from the Ministry of Educa-
tion (97C031703) and National Science Council (NSC96-2320-B-
110-003-MY3) of the Republic of China awarded to C.-Y.D.
3.5. Molecular mechanics calculations
Implementation of the MM2 force field26 in CHEM3D PRO software
from CambridgeSoft Corporation, Cambridge, MA, USA (ver. 9.0,
2005), was used to calculate molecular models.
References and notes
1. Blunt, J. W.; Copp, B. R.; Hu, W. P.; Munro, M. H. G.; Northcote, P. T.; Prinsep, M.
R. Nat. Prod. Rep. 2008, 25, 35.
3.6. Antimicrobial activity
2. Higuchi, R.; Miyamoto, T.; Yamada, K.; Komori, T. Toxicon 1998, 36, 1703.
3. Matthee, G. F.; Konig, G. M.; Wright, A. D. J. Nat. Prod. 1998, 61, 237.
4. Wang, S. K.; Duh, C. Y.; Wu, Y. C.; Wang, Y.; Cheng, M. C.; Soong, K.; Fang, L. S. J.
Nat. Prod. 1992, 55, 1430.
5. Coval, S. J.; Patton, R. W.; Petrin, J. M.; James, L.; Rothofsky, M. L.; Lin, S. L.; Patel,
M.; Reed, J. K.; McPhil, A. T.; Bishop, W. R. Bioorg. Med. Chem. Lett. 1996, 6, 909.
6. Duh, C. Y.; Wang, S. K.; Huang, B. T.; Dai, C. F. J. Nat. Prod. 2000, 63, 884.
7. Yamada, K.; Ryu, K.; Miyamoto, T.; Higuchi, R. J. Nat. Prod. 1997, 60, 798.
8. Subrahmanyam, C.; Rao, C. V.; Anjaneyulu, V.; Satyanarayana, P.; Rao, P. V. S.
Tetrahedron 1992, 48, 3111.
Bacterial strains were grown in LB (Luria-Bertani) broth med-
ium for 24 h at 37 °C. Then, 17 mL LB hard agar (1.5% agar) was
poured into sterile Petri dishes (9 cm) and allowed to set. Next,
2.7 mL molten LB soft agar (0.7% agar, 45 °C) was inoculated with
0.3 mL broth culture of the test organism and poured over the base
hard agar plates forming a homogenous top layer. Sterile paper
disks (Advantec, 8 mm) were placed onto the top layer of the LB
9. Bowdon, B. F.; Coll, J. C.; Heaton, A.; Konig, G.; Bruck, M. A.; Cramer, R. E.; Klein,
D. M.; Scheuer, P. J. J. Nat. Prod. 1987, 50, 650.
agar plates. Ten milliliters (2
l
g/lL) of the tested compounds were
10. Uchio, Y.; Eguchi, S.; Kuramoto, J.; Nakayama, M.; Hase, T. Tetrahedron Lett.
1985, 26, 4487.
11. Tursch, B.; Braekman, J. C.; Daloze, D.; Herin, M.; Karlsson, R. Tetrahedron Lett.
1974, 43, 3769.
applied on to each the filter paper disks. Ampicillin (5
l
g/ L) and
l
the same solvents were served as positive and negative controls.
All plates were incubated at 37 °C, 24 h prior to antibacterial activ-
ity evaluation. The antimicrobial activity of all isolated metabolites
12. Kashman, Y.; Groweiss, A. Tetrahedron Lett. 1977, 13, 1159.
13. Kinamoni, Z.; Groweiss, A.; Carmely, S.; Kashman, Y. Tetrahedron 1983, 39,
1643.
14. Kashman, Y.; Carmely, S.; Groweiss, A. J. Org. Chem. 1981, 46, 3592.
15. Rashid, M. A.; Gustafson, K. R.; Boyd, M. R. J. Nat. Prod. 2000, 63, 531.
16. Bowden, B. F.; Coll, J. C.; Tapiolas, D. M. Aust. J. Chem. 1983, 36, 2289.
17. Bowden, B. F.; Coll, J. C.; Decosta, M. S. L.; Desilva, E. D.; Mackay, M. F.;
Mahendran, M.; Willis, R. H. Aust. J. Chem. 1984, 34, 545.
18. Cheng, S. Y.; Wen, Z. H.; Chiou, S. F.; Wang, S. K.; Hsu, C. H.; Dai, C. F.; Chiang, M.
Y.; Duh, C. Y. Tetrahedron 2008, 64, 9698.
1–8 was tested up to 100 lg/disk on S. enteritidis (ATCC13076). The
bacterial strain was obtained from the American Type Culture Col-
lection. The antibiotic activity evaluation method was conducted
based on previously reports.27,28
3.7. Anti-inflammatory assay
19. Zhang, W.; Krohn, K.; Ding, J.; Miao, Z. H.; Zhou, X. H.; Chen, S. H.; Pescitelli, G.;
Salvadori, P.; Kurtan, T.; Guo, Y. W. J. Nat. Prod. 2008, 71, 961.
20. Li, G.; Zhang, Y.; Deng, Z.; van Ofwegen, L.; Proksch, P.; Lin, W. J. Nat. Prod. 2005,
68, 649.
21. Iwashima, M.; Matsumoto, Y.; Takenaka, Y.; Iguchi, K.; Yamori, T. J. Nat. Prod.
2002, 65, 1441.
22. Ohtani, I.; Kusumi, T.; Kashman, Y.; Kakisawa, H. J. Am. Chem. Soc. 1991, 113,
4092.
23. Kinamoni, Z.; Groweiss, A.; Carmely, S.; Kashman, Y.; Loya, Y. Tetrahedron 1983,
39, 1643.
24. Rodriguez, A. D.; Li, Y.; Dhasmana, H.; Barnes, C. J. Nat. Prod. 1993, 56, 1101.
25. Pham, N. B.; Butler, M. S.; Quinn, R. J. J. Nat. Prod. 2002, 65, 1147.
26. Allinger, N. L. J. Am. Chem. Soc. 1977, 99, 8127.
27. Hou, L.; Shi, Y.; Zhai, P.; Le, G. J. Ethnopharmacol. 2007, 111, 227.
28. Arias, M. E.; Gomez, J. D.; Cudmani, N. M.; Vattuone, M. A.; Isla, M. I. Life Sci.
2004, 75, 191.
29. Ho, F. M.; Lai, C. C.; Huang, L. J.; Kuo, T. C.; Chao, C. M.; Lin, W. W. Br. J.
Pharmacol. 2004, 141, 1037.
30. Park, E. K.; Shin, Y. W.; Lee, H. U.; Kim, S. S.; Lee, Y. C.; Lee, B. Y.; Kim, D. H. Biol.
Pharm. Bull. 2005, 28, 652.
The anti-inflammatory assay was modified from Ho et al.29 and
Park et al.30 Murine RAW 264.7 macrophages were obtained from
the American Type Culture Collection (ATCC, No. TIB-71). The cells
were activated by incubation in medium containing Escherichia coli
LPS (0.01 lg/mL; Sigma) for 16 h in the presence or absence of vari-
ous compounds. Then, cells were washed with ice-cold PBS, lysed in
ice cold lysis buffer, and centrifuged at 20,000g for 30 min at 4 °C.
The supernatant was decanted from the pellet and retained for Wes-
tern blot analysis. Protein concentrations were determined by the
DC protein assay kit (Bio-Rad) modified by the method of Lowry
et al.31 Samples containing equal quantities of protein were sub-
jected to SDS–polyacrylamide gel electrophoresis, and the separated
proteins were electrophoretically transferred to polyvinylidene
difluoride membranes (PVDF; Immobilon-P, Millipore, 0.45 lm pore
size). The resultant PVDF membranes were incubated with blocking
solution and incubated for 180 min with antibody against inducible
nitric oxide synthase (iNOS; 1:1000 dilution; Transduction Labora-
tories) and cyclooxygenase-2 (COX-2; 1:1000 dilution; Cayman
Chemical) protein. The blots were detected using ECL detection re-
agents (Perkin–Elmer, Western Blot Chemiluminescence Reagent
31. Lowry, D. H.; Rosebrough, N. J.; Farr, A. L.; Randall, R. J. J. Biol. Chem. 1951, 193,
265.
32. Knizewski, L.; Kinch, L.; Grishin, N. V.; Rychlewski, L.; Ginalski, K. J. Virol. 2006,
80, 2575.
33. Tachiwana, H.; Shimura, M.; Nakai-Murakami, C.; Tokunaga, K.; Takizawa, Y.;
Sata, T.; Kurumizaka, H.; Ishizaka, Y. Cancer Res. 2006, 66, 627.